1-[4-(3-chloropropoxy)-3-methoxyphenyl]ethanone

We are 1-[4-(3-chloropropoxy)-3-methoxyphenyl]ethanone CAS:58113-30-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1-[4-(3-chloropropoxy)-3-methoxyphenyl]ethanone
CAS.NO:58113-30-7
Synonyms:1-[4-(3-chloropropoxy)-3-methoxyphenyl]ethanone
4-(3-chloropropoxy)-3-methoxyacetophenone
3-chloro-1-(4-acetyl-2-methoxyphenoxy)-propane
3-(p-acetyl-o-methoxyphenoxy)-propyl chloride
chloropropoxymethoxyphenylethanone
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 367.0±27.0 °C at 760 mmHg
Molecular Formula C12H15ClO3
Molecular Weight 242.699
Flash Point 149.8±22.7 °C
Vapour Pressure 0.0±0.8 mmHg at 25°C
Index of Refraction 1.509
 
Specification:
Appearance:White crystalline powder
Assay(HPLC):≥98.0-102.0%
Loss on drying:≤0.5%
Residue on ignition:≤0.1%
Heavy metals:≤20ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Iloperidone(CAS:133454-47-4).

1-[4-(3-chloropropoxy)-3-methoxyphenyl]ethanone


Related News: Bulk drug substances mainly include vitamins, antibiotics, hormones, antipyretics and analgesics, among which vitamin C, erythromycin thiocyanate, penicillin, azithromycin, and semi-synthetic cephalosporins are the most concentrated products in the industry in terms of production and overcapacity.1034-01-1 Bulk drug substances mainly include vitamins, antibiotics, hormones, antipyretics and analgesics, among which vitamin C, erythromycin thiocyanate, penicillin, azithromycin, and semi-synthetic cephalosporins are the most concentrated products in the industry in terms of production and overcapacity.3-Bromo-2-chloropyridine CAS:52200-48-3 The company’s pharmaceutical intermediate business is expected to maintain a growth rate of more than 30%.Ammonium thiosulfate CAS:7783-18-8 Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.

Related Products
Product Name
4-Methlybenzophenone View Details
N-methylaniline View Details
4-Methyl-3-nitropyridine View Details
2-Methylpyrazine manufacturer 2-Thiophenethiol manufacturer 1,3-Dibromo-2-propanol manufacturer Palmitoyl Dipeptide-5 manufacturer (alphaR)-alpha-[[[2-(4-Aminophenyl)ethyl]amino]methyl]benzenemethanol hydrochloride manufacturer